Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|29|3|263-267

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.29, Iss.3, 2010-01, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recanalization within One Hour after Intravenous Tissue Plasminogen Activator Is Associated with Favorable Outcome in Acute Stroke Patients

By  

European Neurology, Vol. 63, Iss. 6, 2010-06 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Validation of FLAIR Hyperintense Lesions as Imaging Biomarkers to Predict the Outcome of Acute Stroke after Intra-Arterial Thrombolysis following Intravenous Tissue Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 35, Iss. 5, 2013-05 ,pp. : 461-468

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischaemic Stroke: Preliminary Experience with Recombinant Tissue Plasminogen Activator in the UK

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 438-442

Karger

Access to resources Recommend Favorite

Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 288-295

Karger

Access to resources Recommend Favorite

Rapid Neurological Recovery after Intravenous Tissue Plasminogen Activator in Stroke: Prognostic Factors and Outcome

By  

Cerebrovascular Diseases, Vol. 31, Iss. 3, 2010-12 ,pp. : 278-283

Karger

Access to resources Recommend Favorite